Community/Retail

A session held at the ASHP 2017 Summer Meeting and Exhibition addressed pharmacists impact on the future health care and the inclusion of pharmacists in interdisciplinary teams.

As the primary stewards of their patients’ medication care, pharmacists are ideally placed to identify and reduce harmful medication-related events, according to the Institute for Safe Medication Practices.

Hospitals often discuss the importance of reporting errors, but is lack of feedback to blame why some pharmacists may not report errors?

Automation and technology have facilitated bar code dispensing.

Matthew Grissinger, BSPharm, offers advice for health-system pharmacists on catching potential harmful medication errors.

TPN compounding machines can help reduce potential disensing errors.

To address escalating drug costs, health care payers increasingly are adopting benefit designs that aim to identify and pay for medications based on their value.

Susan G. Komen Chicago has set a bold goal of helping reduce breast cancer deaths by 50% in the U.S. by 2026.

What are the latest drugs available in primary care and what role do they play in pharmacy practice?

Ethical dilemmas do surface from time to time in the pharmacy.

At the ASHP 2017 Summer Meeting and Exhibition held in Minneapolis, Minnesota, several speakers spoke about the misuse and abuse of opioids. In this clip, Tim Stratton, PhD, BCPS, FAPhA, Professor of Pharmacy Practice at the University of Minnesota, discusses the ethical dimensions of the opioid crisis from a pharmacy practice and public health perspective.

HPV vaccination is currently indicated for the prevention of cervical, vulvar, and vaginal cancers in women, and anal cancers in both women and men.

The impact that generics have on bringing down the cost of branded drugs needs to happen in the biologics space so the industry can save money and improve access to medications and population outcomes.

Mark S. Soberman, MD, MBA, FACS, the 2017 to 2018 President of the Association of Community Cancer Centers (ACCC), discusses his vision for the next-generation of multidisciplinary care in an interview during the 2017 ASCO Annual Meeting.

This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings, and more. Our Week in Review is a can't miss for the busy pharmacy professional.

Learn about the new products and expanded indications approved by the FDA in May 2017.

If you get really lucky, you might find that your company has a policy already in place that provides extra compensation for obtaining certain certifications regardless of employee performance.

Due to the increasing rise in drug abuse from opioids and recent safety warnings regarding NSAIDs, practitioners are beginning to show more interest in topical agents.

The job of a pharmacist entails way more than just counting pills.

The benefits of statins may be more far-reaching than previously thought, according to research presented at EuroCMR 2017 last week.

Is Mad Men illustrating that one cannot be creative in their daily workflow?

Cardinal Health Specialty Solutions has introduced 2017 Oncology Insights, the first in a series of research reports to provide perspective on key issues for specialty care providers, biopharma companies, and other healthcare stakeholders.

Many community pharmacists wonder what they can and should do for their patients who have HIV.

Here are some sessions to watch for in our coverage at this year’s meeting.

In 2014, the drug was granted accelerated approval to treat patients with ALK-positive NSCLC whose disease progressed on or who are intolerant to crizotinib.

Isentress has been used as a component of treatment regimens for patients diagnosed with HIV-1 for almost a decade.